Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Allosteric Regulation01:08

Allosteric Regulation

57.2K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.2K
Enzyme Inhibition01:30

Enzyme Inhibition

77.5K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
77.5K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

5.6K
Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.6K
Enzymes02:34

Enzymes

80.2K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
80.2K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

7.8K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.8K
Feedback Inhibition00:46

Feedback Inhibition

53.4K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
53.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Olverembatinib: real progress in BCR::ABL1 leukemia?

Haematologica·2026
Same author

Immunological mechanisms and therapeutic advances in chronic myeloid leukemia.

Leukemia·2026
Same author

DruGUI 2.0: mapping protein druggability with probe-based molecular dynamics.

Bioinformatics (Oxford, England)·2026
Same author

15-LOX-catalytic bias towards ether-(alkenyl)-ETE-PEs oxidation bestows selectivity of PRO-ferroptotic cell death signaling.

Nature communications·2026
Same author

Structural and molecular determinants of glutamate transporter allosteric modulators.

Molecular pharmacology·2026
Same author

Small Molecule Activators of Protein Phosphatase 2A Exert Global Stabilizing Effects on the Scaffold PR65.

JACS Au·2026

相关实验视频

Updated: May 14, 2025

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects
13:57

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects

Published on: February 18, 2014

29.0K

对菌抑制剂的耐药性

Ian R Outhwaite1, Isabelle Kwan2, Ariel Leyte-Vidal3

  • 1Department of Pharmacological Sciences, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.

Journal of molecular biology
|April 11, 2025
PubMed
概括
此摘要是机器生成的。

菌抑制剂提供了新的治疗选择,但也可能面临抗药性. 了解这些抵抗机制是开发弹性疗法的关键,可能是通过组合治疗.

关键词:
亚洛斯特菌是什么意思?药物耐药性 耐药性 药物耐药性酵素酶是一种酶.这是一个机制机制.

更多相关视频

A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
10:28

A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors

Published on: August 17, 2019

9.4K
NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases
10:24

NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases

Published on: June 30, 2019

9.9K

相关实验视频

Last Updated: May 14, 2025

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects
13:57

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects

Published on: February 18, 2014

29.0K
A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
10:28

A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors

Published on: August 17, 2019

9.4K
NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases
10:24

NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases

Published on: June 30, 2019

9.9K

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 分子生物学分子生物学
  • 药物发现 药物发现 药物发现

背景情况:

  • 阿洛斯特抑制剂是克服对奥托斯特抑制剂耐药性的有价值的治疗方法.
  • 然而,对全抑制剂本身的耐药性可能会出现,限制长期疗效.

研究的目的:

  • 审查对所有菌抑制剂耐药性的分子机制.
  • 探索克服这种抗性的策略,并开发出更有弹性的疗法.

主要方法:

  • 关于抵抗机制的文献综述.
  • 分析分子适应和参与抗性的信号通路.
  • 探索组合治疗策略的探索.

主要成果:

  • 抵抗机制包括改变的抑制剂结合,破坏的全性通路和非目标效应.
  • 药物排放和补偿信号通路有助于抵抗.
  • 比托普抑制剂和组合疗法在缓解耐药性方面表现有前途.

结论:

  • 了解各种抗性机制对于治疗开发至关重要.
  • 组合策略,包括双抑制剂,对于克服全抑制剂耐药性至关重要.
  • 需要进一步的研究来设计下一代抗药性疗法.